- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05665933
Acceptance and Commitment Therapy and Test Anxiety
January 4, 2023 updated by: Kubra Tan, Artvin Coruh University
Acceptance and Commitment Therapy and Test Anxiety in Adolescents
The aim of this study is to evaluate the effect of acceptance and commitment therapy-based psychoeducation on test anxiety, study skills and psychological flexibility on adolescents.
test anxiety scale, study skills scale and psychological flexibility scale are data collection tools.
The pretest-posttest is a randomized controlled trial.
Experimental and control groups were formed.
A 6-week psychoeducation will be applied to the experimental group.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The aim of this study is to determine the effect of acceptance and commitment therapy-based psychoeducation given to adolescents on test anxiety, study skills and psychological flexibility.The research was designed as a randomized controlled study with pretest, posttest, experimental and control groups aiming to examine the results of Acceptance and Commitment Therapy (ACT) based psychoeducation for test anxiety and study skills.
The number of effects of the study was targeted by the randomization method among the adolescents who met the inclusion criteria and accepted the application.
In the power analysis, the evaluation of the number of increase is aimed at 0.05 aggression level at the 95% confidence interval, and 52 adolescents, 26 experimental and 26 control groups, to reach 80% power.
Randomization methods were used so that individuals could be assigned to the experimental groups with equal chance, similar to the scores they obtained from the laboratory test anxiety periods.
52 adolescents who met the clinical research criteria for randomization were divided into 2 groups using the irregular numbers table, this group was named as the experimental and control groups by drawing lots.
The group that came out first in the lottery at this stage was accepted as the experimental group.
Psychoeducation is planned to be held between December 2022 and February 2023.
Study Type
Interventional
Enrollment (Anticipated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Kübra Tan, Master
- Phone Number: +90 5544339729
- Email: tankubra@hotmail.com
Study Contact Backup
- Name: Ayşe Okanlı, Prof. Dr.
- Phone Number: +90 5423787828
- Email: a.okanli@gmail.com
Study Locations
-
-
-
Artvın, Turkey
- Recruiting
- ArtvinCoruhU
-
Contact:
- Kubra Tan, Master
- Phone Number: 6056 +90 0466 215 1000
- Email: kubratan@artvin.edu.tr
-
Contact:
- Ayşe Okanlı
-
Principal Investigator:
- Kubra TAN, Master
-
Sub-Investigator:
- Ayşe Okanlı, Prof.Dr.
-
-
Center
-
Artvın, Center, Turkey
- Recruiting
- ArtvinCoruhU
-
Contact:
- Kubra Tan, Master
- Phone Number: 6056 +90 0466 215 1000
- Email: kubratan@artvin.edu.tr
-
Contact:
- Ayşe Okanlı
-
Principal Investigator:
- Kubra TAN, Master
-
Sub-Investigator:
- Ayşe Okanlı, Prof.Dr.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Students' willingness to participate in research
- Students being 11th graders
- Getting a score of 50 or more on the test anxiety scale
Exclusion Criteria:
- Any degree of cognitive decline or impairment
- Presence of depressive disorder
- Presence of serious psychiatric disorder
- Being under treatment for a psychiatric condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: THE EFFECT OF ACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION
PSYCHOEDUCATION PROGRAM Total Duration: 6 Weeks Session Duration: 90 min Frequency: 1 day per week Number of People: 30
|
Total Duration: 6 Weeks Session Duration: 90 min Frequency: 1 day per week Number of People: 30
|
|
No Intervention: THE EFFECT OF ACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION ON EXAM ANXIETY IN ADOLESCENTS
Similar training will be provided after the study is completed.
Number of People: 30
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change study skills in adolescents.
Time Frame: 6 weeks
|
Change in test study skills scale.A maximum of 165 and a minimum of 55 points are obtained from the study skills scale.
A high score defines the ability to study effectively.
|
6 weeks
|
|
Change of Exam Anxiety Scale Total Score
Time Frame: 6 weeks
|
Change in test anxiety scale at the end of 6 weeks.
The highest score from the test anxiety scale is 80 and the lowest score is 20.
A high score defines high anxiety.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change the level of psychological flexibility
Time Frame: 6 weeks
|
Change in test psychological flexibility.
A maximum of 196 and a minimum of 28 points are obtained from the psychological flexibility scale.
A higher score reflects higher psychological flexibility.
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kübra Tan, https://www.artvin.edu.tr/kubra-tan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2022
Primary Completion (Actual)
December 15, 2022
Study Completion (Anticipated)
July 1, 2023
Study Registration Dates
First Submitted
December 7, 2022
First Submitted That Met QC Criteria
December 16, 2022
First Posted (Actual)
December 27, 2022
Study Record Updates
Last Update Posted (Actual)
January 5, 2023
Last Update Submitted That Met QC Criteria
January 4, 2023
Last Verified
January 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Artvin Coruh U
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
The name and results of the study will be shared.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Therapy, Directly Observed
-
Universidad de BurgosCompletedElectrode Site Reaction | Therapy, Directly ObservedSpain
-
Muğla Sıtkı Koçman UniversityCompletedTherapy, Directly ObservedTurkey (Türkiye)
-
Universidad de BurgosNot yet recruitingTherapy | Electrode Site Reaction | Directly Observed Therapy
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic Prostate Cancer | Therapy, Directly ObservedChina
-
Saint Michael's Medical CenterHoffmann-La RocheCompletedHIV Infections | Directly Observed TherapyUnited States
-
Ligue Pulmonaire GenevoiseUniversity Hospital, GenevaCompleted
-
I.R.C.C.S. Fondazione Santa LuciaUniversità Foro Italico Roma; CNR PisaNot yet recruitingParkinson Disease | Metabolic Disease | Gait Analysis | Therapy, Directly Observed
-
State University of New York at BuffaloNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingAsthma in Children | Directly Observed TherapyUnited States
-
The Affiliated Hospital of Xuzhou Medical UniversityAffiliated Hospital of Jiangnan University; Suzhou Municipal Hospital; Affiliated... and other collaboratorsNot yet recruitingDiabetic Foot Ulcer | Therapy, Directly Observed
-
PepsiCo Global R&DCompletedMaximum Observed Plasma Glucose Concentration (Cmax)United States
Clinical Trials on ACCEPTANCE AND COMMITMENT THERAPY-BASED PSYCOEDUCATION
-
PLA Rocket Force Characteristic Medical CenterBeijing Municipal Science & Technology CommissionCompletedAcute Stroke Patients With DepressionChina
-
Tugba YildirimCompletedPsychological Flexibility | Somatic SymptomTurkey
-
Recep Tayyip Erdogan UniversityActive, not recruitingKidney Failure, ChronicTurkey
-
Kubra TOHUMCUCompletedBipolar Disorder | Coping SkillsTurkey
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
University of GaziantepCompleted
-
University of California, Los AngelesNational Institute of Mental Health (NIMH)CompletedSocial Anxiety DisorderUnited States
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
Maastricht University Medical CenterCompletedNo Specific ConditionsNetherlands
-
Ataturk UniversityCompletedStress | Anxiety | Mental Disorder | Acceptance and Commitment Therapy | Psychological Well-being | Depression DisordersTurkey